Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review

This systemic review highlights the safety of JAK inhibitors according to MACE occurrence in patients with SpA when compared to placebo. These results need to be interpreted with caution regarding the limited long-term data and small sample sizes in clinical trials. Long-term studies are needed to clarify these risks.

Institutions

Publication Details

Journal
La Tunisie Médicale
Published
2025-11-09
DOI
https://doi.org/10.62438/tunismed.v103i9.6218
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review

La Tunisie Médicale
Spondyloarthritis Studies and Treatments
article

Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review

article en

Abstract

This systemic review highlights the safety of JAK inhibitors according to MACE occurrence in patients with SpA when compared to placebo. These results need to be interpreted with caution regarding the limited long-term data and small sample sizes in clinical trials. Long-term studies are needed to clarify these risks.

La Tunisie MédicaleVol. 103(9)
Tunis University (TN), Military Hospital of Tunis (TN), Tunis El Manar University (TN)
Good health and well-being
Openalex Percentile: Top 29%
Spondyloarthritis Studies and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review · La Tunisie Médicale (2025) | TGRS Research Map | TGRS